Every day in every hospital in the world blood is needed. The only way to get it is from donations, since blood cannot be created artificially. Each altruist action may serve to help three different patients. In Catalonia, for the system to...
During the first half of the year, the revenues of the Catalan multinational pharmaceutical company Grifols rose by 16.7% to €1.61 bilion, 75% of which came from the Bioscience division and 18% from Diagnostic. Compared to the first...
A plasma fractionation plant installed in Clayton, North Carolina by the company Grífols was unveiled on Tuesday by the President of the Catalan Government, Artur Mas, along with the President and CEO of the pharmaceutical,...
The profits of Catalan pharmaceutical company Grífols in 2013 grew by 34.6% over the previous year, reaching €345.6 million, as reported by the multinational to the Spanish Stock Exchange Regulation Authority...
The Catalan pharmaceutical company Grifols, the third world leader in the production of blood plasma based technologies, has seen its turnover increase by 15% in the first half of 2012 to €1.32 billion. Its net profit for the first half of...
The Catalan pharmaceutical company Grífols, third worldwide company in plasma derivatives, has signed a cooperation agreement with the Shanghai Blood Bank. The agreement, which strengthens the presence of the Catalan company in China, promotes...
The Federation of Blood Donors in Catalonia wants to reach the young population and to raise the number of donations. Besides, the Catalan pharmaceutical company Grifols asked for a change in the law in order to pay for giving blood. This...
The Catalan pharmaceutical and chemical company was identified in a Wikileaks cable from the U.S. State Department as one of three strategic items the United States had in Spain, together with the natural gas pipeline from Algeria and the...
